Yale Researchers Identify New Role for STING in Treatment of Head and Neck Cancer
A recent study conducted by Yale Cancer Center reports the discovery of a new role for STimulator of INterferon Genes (STING) for head and neck cancer treatment. Previously, STING has been related to the immune response involved in DNA damage. However, this study aims to focus on STING’s new role in tumor DNA damage response